Exploring inorganic compounds to create new medical solutions
Using Inorganic Chemistry to Understand and Solve Health-Related Problems
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA SANTA CRUZ · NIH-10938305
This study is exploring new ways to create medicines using special inorganic compounds to help treat serious health problems like carbon monoxide poisoning and leishmaniasis, with the hope of finding faster and more effective treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA SANTA CRUZ (nih funded) |
| Locations | 1 site (SANTA CRUZ, UNITED STATES) |
| Trial ID | NIH-10938305 on ClinicalTrials.gov |
What this research studies
This research focuses on leveraging the unique properties of inorganic compounds to develop new medicinal solutions that complement traditional organic chemistry approaches. The project aims to address critical health issues, such as finding an effective antidote for carbon monoxide poisoning and improving the understanding of antimony-containing drugs used for treating leishmaniasis. By utilizing innovative methodologies from inorganic chemistry, the research seeks to solve problems that have remained unsolved with conventional methods. Patients may benefit from new treatments that could be more effective and faster acting than current options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from carbon monoxide poisoning or those affected by leishmaniasis.
Not a fit: Patients with conditions unrelated to carbon monoxide poisoning or leishmaniasis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective antidotes for carbon monoxide poisoning and improved treatments for leishmaniasis.
How similar studies have performed: While the approach of using inorganic compounds in medicinal chemistry is innovative, there have been previous successes in related areas, indicating potential for breakthroughs.
Where this research is happening
SANTA CRUZ, UNITED STATES
- UNIVERSITY OF CALIFORNIA SANTA CRUZ — SANTA CRUZ, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JOHNSTONE, TIMOTHY CHARLES — UNIVERSITY OF CALIFORNIA SANTA CRUZ
- Study coordinator: JOHNSTONE, TIMOTHY CHARLES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.